Analysts Cut Oracle Targets to $285 and $205 After $30B Debt Raise
Citizens and BMO trimmed Oracle’s price targets to $285 (from $342) and $205 (from $270) after its $30 billion debt financing and convertible-related selling, while retaining outperform ratings. Another analyst notes Oracle shares are down over 50% since September despite projections of sharply rising revenue.
1. Analysts Trim Price Targets
Citizens lowered its Oracle price target to $285 from $342 and BMO Capital cut its target to $205 from $270, with both firms maintaining outperform ratings on the stock. The revisions reflect updated financial models following recent corporate funding and market developments.
2. Debt Financing and Convertible Selling
Oracle raised $30 billion through debt issuance to support its strategic investments, but technical selling tied to its mandatory convertible notes and tighter credit default swap spreads exerted downward pressure on share prices.
3. Shares Down Over 50% Since September
The stock has declined more than 50% since September as investors reacted to funding dilution concerns and broader tech-sector volatility. This pullback has drawn attention from value‐oriented analysts who view the dip as a potential entry point.
4. Revenue Outlook and Future Catalysts
Despite recent share weakness, Oracle projects sharply rising revenue driven by growth in cloud infrastructure and AI services. Continued execution on its capital deployment strategy and expanding AI-related offerings could support a valuation rebound.